RUGGIERO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.214
AS - Asia 902
EU - Europa 707
SA - Sud America 191
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.039
Nazione #
US - Stati Uniti d'America 1.179
SG - Singapore 390
BR - Brasile 169
CN - Cina 145
RU - Federazione Russa 131
HK - Hong Kong 123
IT - Italia 100
FR - Francia 91
VN - Vietnam 87
GB - Regno Unito 78
DE - Germania 77
SE - Svezia 72
IE - Irlanda 68
KR - Corea 62
ID - Indonesia 39
FI - Finlandia 29
CA - Canada 20
IN - India 15
AT - Austria 13
NL - Olanda 12
AR - Argentina 9
BE - Belgio 9
MX - Messico 9
LT - Lituania 8
TG - Togo 8
JP - Giappone 7
BD - Bangladesh 6
IQ - Iraq 5
TR - Turchia 5
UZ - Uzbekistan 5
EC - Ecuador 4
ES - Italia 4
MA - Marocco 4
PK - Pakistan 4
UA - Ucraina 4
ZA - Sudafrica 4
PL - Polonia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
LV - Lettonia 2
PA - Panama 2
SN - Senegal 2
VE - Venezuela 2
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 3.039
Città #
Dallas 411
Chandler 213
Singapore 164
Hong Kong 123
Southend 68
Dublin 66
Jakarta 38
Dong Ket 36
Ashburn 34
Lawrence 32
Princeton 32
Beijing 30
Sindelfingen 30
Verona 27
Los Angeles 22
Columbus 21
Seoul 21
Jacksonville 20
Redondo Beach 20
Lappeenranta 18
New York 18
Seattle 17
The Dalles 15
Nuremberg 14
Wilmington 13
Munich 12
Rome 12
Santa Clara 12
São Paulo 12
Woodbridge 12
Ann Arbor 11
Buffalo 11
Milan 11
Hanoi 8
Lomé 8
Toronto 8
Vienna 8
Council Bluffs 7
Ho Chi Minh City 7
Moscow 7
Norwalk 7
Redmond 7
Tokyo 7
Bangalore 6
Brussels 6
Frankfurt am Main 6
Guangzhou 6
Boardman 5
Brasília 5
Chennai 5
Dongguan 5
Mexico City 5
Montreal 5
Rio de Janeiro 5
Tashkent 5
Amsterdam 4
Baghdad 4
Guarulhos 4
Helsinki 4
Houston 4
Johannesburg 4
Limeira 4
Ottawa 4
Salvador 4
Shenyang 4
Walsall 4
Atlanta 3
Belo Horizonte 3
Hangzhou 3
Kent 3
Mauá 3
Nanjing 3
San Francisco 3
San Mateo 3
Tianjin 3
Tombolo 3
Turku 3
Ankara 2
Boston 2
Brescia 2
Brooklyn 2
Cambridge 2
Campinas 2
Canoas 2
Contagem 2
Dakar 2
Elora 2
Garibaldi 2
Grottammare 2
Ha Long 2
Haikou 2
Hebei 2
Indaiatuba 2
Jinan 2
Joinville 2
Malcesine 2
Maringá 2
Nanchang 2
Nova Iguaçu 2
Osasco 2
Totale 1.857
Nome #
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 302
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 169
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 163
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 101
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 98
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 87
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 83
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 80
Comparative analysis and generation of a robust HIV-1 DNA quantification assay 77
Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals 75
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 75
Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children 70
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 70
BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed? 70
Highly specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA 69
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 68
Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy 68
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 67
During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ 64
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 64
The immunology of Multisystem Inflammatory Syndrome in children with COVID-19 64
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 64
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 62
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines 61
Clinical, virological and immunological subphenotypes in a cohort of early treated HIV-infected children 60
The HCV envelope glycoprotein down-modulates NF-κB signalling and associates with stimulation of the host endoplasmic reticulum stress pathway 60
Pseudotyped viruses as a molecular tool to monitor humoral immune responses against SARS-CoV-2 via neutralization assay 59
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine et al 59
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring 57
Generation of liposomes to study the effect of Mycobacterium Tuberculosis lipids on HIV-1 cis- and trans-infections 54
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana 53
Measuring the success of HIV-1 cure strategies 51
HIV and SARS-CoV-2 co-infection: from population study evidence to in vitro studies 50
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 50
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection 49
Measuring proviral HIV-1 DNA: hurdles and improvements to an assay monitoring integration events utilising human Alu repeat sequences 47
A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection 46
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 45
Targeted protein degradation tools: overview and future perspectives 45
Utility of integrated HIV-1 DNA quantification in cure studies 45
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 40
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1 39
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 28
Totale 3.108
Categoria #
all - tutte 14.410
article - articoli 13.307
book - libri 0
conference - conferenze 1.103
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.820


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 3 4 2 0 2 2 0 32 64
2021/2022140 8 13 1 5 1 1 2 12 7 7 41 42
2022/2023600 42 63 55 96 46 130 10 40 82 9 18 9
2023/2024273 13 20 17 37 18 34 29 15 4 29 36 21
2024/2025999 44 52 35 193 25 41 86 59 161 64 65 174
2025/2026852 189 140 461 62 0 0 0 0 0 0 0 0
Totale 3.108